{Reference Type}: Journal Article
{Title}: Pathogenetic and molecular classifications of soft tissue and bone tumors: A 2024 update.
{Author}: Patrichi AI;Gurzu S;
{Journal}: Pathol Res Pract
{Volume}: 260
{Issue}: 0
{Year}: 2024 Aug 13
{Factor}: 3.309
{DOI}: 10.1016/j.prp.2024.155406
{Abstract}: Soft tissue and bone tumors comprise a wide category of neoplasms. Their diversity frequently raises diagnostic challenges, and therapeutic options are continuously developing. The therapeutic success rate and long-term prognosis of patients have improved substantially due to new advances in immunohistochemical and molecular biology techniques. A fundamental contribution to these achievements has been the study of the tumor microenvironment and the reclassification of new entities with the updating of the molecular pathogenesis in the revised 5th edition of the Classification of Soft Tissue Tumors, edited by the World Health Organization. The proposed molecular diagnostic techniques include the well-known in situ hybridization and polymerase chain reaction methods, but new techniques such as copy-number arrays, multiplex probes, single-nucleotide polymorphism, and sequencing are also proposed. This review aims to synthesize the most recent pathogenetic and molecular classifications of soft tissue and bone tumors, considering the major impact of these diagnostic tools, which are becoming indispensable in clinicopathological practice.